Companies: 10,795·Total market cap: $144.5T
NovoCure Limited

NovoCure Limited

NVCRNASDAQHealthcare● Active
$17.27
+$0.11(+0.64%)
Market Cap$2.0B
P/E Ratio
52W High$19.25
52W Low$9.82
Overview

NovoCure Limited(NVCR)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · NVCR · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.66B$0.61B$0.51B$0.54B$0.54B
Cost of Revenue$0.17B$0.14B$0.13B$0.11B$0.11B
Gross Profit$0.49B$0.47B$0.38B$0.42B$0.42B
Gross Margin %(computed)74.54%77.33%74.81%78.64%78.53%
Operating Expenses
R&D Expenses$0.22B$0.21B$0.22B$0.21B$0.20B
G&A Expenses$0.18B$0.19B$0.16B$0.13B$0.13B
Total Operating Expenses$0.64B$0.64B$0.61B$0.51B$0.46B
Operating Income($0.15B)($0.17B)($0.23B)($0.09B)($0.04B)
Operating Margin %(computed)-23.47%-28.17%-45.72%-16.64%-8.29%
Interest Income$0.02B$0.05B$0.05B$0.02B$0.00B
Interest Expense$0.00B$0.01B$0.00B$0.01B$0.01B
Income Before Tax($0.14B)($0.13B)($0.19B)($0.08B)($0.05B)
Income Tax Expense($0.00B)$0.04B$0.02B$0.01B$0.01B
Net Income($0.14B)($0.17B)($0.21B)($0.09B)($0.06B)
Net Margin %(computed)-20.79%-27.86%-40.65%-17.20%-10.91%
Per Share & EBITDA
EPS (Basic)$-1.22$-1.56$-1.95$-0.88$-0.56
Wtd Avg Shares0.11B0.11B0.11B0.10B0.10B
EBITDA($0.12B)($0.11B)($0.18B)($0.07B)($0.04B)
EBITDA Margin %(computed)-18.17%-18.11%-34.84%-12.62%-7.17%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解NovoCure Limited

关于NovoCure Limited(NVCR)损益表

NovoCure Limited(NVCR)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,NVCR实现营收$0.66B,毛利润$0.49B(毛利率74.54%),净利润($0.14B)(净利率-20.79%)。

常见问题

NVCR · 4 问

NovoCure Limited(NVCR)2025财年营收为$0.66B,同比up8.3%。

NVCR revenueNVCR salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08